Infini Resources: An amazing array of uranium geological indicators and no drill holes – until now!

Listen to ASX-listed Infini Resources Managing Director Charles Armstrong talk to Matt Birney on the Bulls N’ Bears Report about Infini’s upcoming maiden drill program into what Infini says are the highest-grade uranium soil samples in the history of exploration. 

See omnystudio.com/listener for privacy information.

Empire Energy: The race is on – will this company be the first to market with Beetaloo gas?

Listen to ASX-listed Empire Energy Managing Director Alex Underwood talk to Matt Birney on the Bulls N’ Bears Report about Empire’s first full-scale development well in the biblical sized Beetaloo gas basin that will likely see it become the first ever gas producer out of the Beetaloo in the NT.

See omnystudio.com/listener for privacy information.

Plenti Group: A lovely set of numbers backed by a $2.3b loan book

Listen to ASX-listed Plenti Group CEO Adam Bennett talk to Matt Birney on the Bulls N’ Bears Report about Plenti’s lovely set of six monthly numbers backed by its rampant $2.3b loan book. 

See omnystudio.com/listener for privacy information.

Great Southern Mining: Ok so this could be serious – a screaming IP anomaly in copper-gold elephant country 

Listen to ASX-listed Great Southern Mining Managing Director Matt Keane talk to Matt Birney on the Bulls N’ Bears Report about why farm-in partner Gold Fields Ltd is spending millions on this ground – a move that looks like it just paid off.

See omnystudio.com/listener for privacy information.

Hot Chili: A strategic land acquisition that will make this massive copper-gold project even bigger!

Listen to ASX-listed Hot Chili Managing Director Christian Easterday talk to Matt Birney on the Bulls N’ Bears Report about a strategic land acquisition that is likely to make the largest copper-gold project on the ASX outside of BHP even larger.

See omnystudio.com/listener for privacy information.

Javelin Minerals: Following in the golden footsteps of Spectrum and Spartan?

Listen to ASX-listed Javelin Minerals Executive Chairman Brett Mitchell talk to Matt Birney on the Bulls N’ Bears Report about Javelin’s plan to emulate the spectacular successes of Spectrum Metals and Spartan Resources, both of which found multimillion-dollar gold deposits near old historic open pits. 

See omnystudio.com/listener for privacy information.

Dateline Resources: Barrick gave up this gold project and now it will make $47m a year!

Listen to ASX-listed Dateline Resources Managing Director Steve Baghdadi talk to Matt Birney on the Bulls N’ Bears Report about Dateline’s scoping study on a project in the USA it snatched from Barrick Gold 3 years ago, that will churn out 75,000 ounces of gold a year for at least 8 years.

See omnystudio.com/listener for privacy information.

Lithium Australia: Sure beats mining it – sucking millions in lithium and nickel out of old lithium batteries

Listen to ASX-listed Lithium Australia Managing Director Simon Linge talk to Matt Birney on the Bulls N’ Bears Report about Lithium Australia’s lithium battery recycling division that has hit its straps with a record quarterly profit derived from sucking lithium and nickel out of old lithium batteries.

See omnystudio.com/listener for privacy information.

Kali Metals: Why are mega-miners like Min Res and SQM hanging around this ASX junior?

Listen to ASX-listed Kali Metals Managing Director Paul Adams talk to Matt Birney on the Bulls N’ Bears Report about Kali’s multimillion-dollar WA farm in deal with one of the biggest lithium miners on the planet.

See omnystudio.com/listener for privacy information.

Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer? 

Listen to ASX-listed Clarity Pharmaceuticals Executive Chair Alan Taylor talk to Matt Birney on the Bulls N’ Bears Report about Clarity’s amazing clinical trial results that saw a complete response in one patient and lots with a 90 per cent plus reduction in signs of prostate cancer using “copper” based radiopharmaceuticals.

See omnystudio.com/listener for privacy information.